These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 28986592)
21. A First-Passage Model of Intravitreal Drug Delivery and Residence Time-Influence of Ocular Geometry, Individual Variability, and Injection Location. Lamirande P; Gaffney EA; Gertz M; Maini PK; Crawshaw JR; Caruso A Invest Ophthalmol Vis Sci; 2024 Oct; 65(12):21. PubMed ID: 39412819 [TBL] [Abstract][Full Text] [Related]
22. Differentially cleaving peptides as a strategy for controlled drug release in human retinal pigment epithelial cells. Bhattacharya M; Sarkhel S; Peltoniemi J; Broadbridge R; Tuomainen M; Auriola S; Urtti A J Control Release; 2017 Apr; 251():37-48. PubMed ID: 28213274 [TBL] [Abstract][Full Text] [Related]
23. Effects of enzymatic degradation on dynamic mechanical properties of the vitreous and intravitreal nanoparticle mobility. Huang D; Chen YS; Xu Q; Hanes J; Rupenthal ID Eur J Pharm Sci; 2018 Jun; 118():124-133. PubMed ID: 29574081 [TBL] [Abstract][Full Text] [Related]
25. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia. Chen YS; Green CR; Wang K; Danesh-Meyer HV; Rupenthal ID Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):378-86. PubMed ID: 25497487 [TBL] [Abstract][Full Text] [Related]
26. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy. Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of coupled convective-diffusive transport of drugs administered by intravitreal injection and controlled release implant. Park J; Bungay PM; Lutz RJ; Augsburger JJ; Millard RW; Sinha Roy A; Banerjee RK J Control Release; 2005 Jul; 105(3):279-95. PubMed ID: 15896868 [TBL] [Abstract][Full Text] [Related]
28. Arginine-tagging of polymeric nanoparticles via histidine to improve cellular uptake. Chiu JZ; Tucker IG; McLeod BJ; McDowell A Eur J Pharm Biopharm; 2015 Jan; 89():48-55. PubMed ID: 25460582 [TBL] [Abstract][Full Text] [Related]
29. Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide. Wang C; Hou H; Nan K; Sailor MJ; Freeman WR; Cheng L Exp Eye Res; 2014 Dec; 129():74-82. PubMed ID: 25446320 [TBL] [Abstract][Full Text] [Related]
30. Intravitreal injection of rapamycin-loaded polymeric micelles for inhibition of ocular inflammation in rat model. Wu W; He Z; Zhang Z; Yu X; Song Z; Li X Int J Pharm; 2016 Nov; 513(1-2):238-246. PubMed ID: 27609662 [TBL] [Abstract][Full Text] [Related]
31. Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution. Kane A; Barza M; Baum J Invest Ophthalmol Vis Sci; 1981 May; 20(5):593-7. PubMed ID: 6971281 [TBL] [Abstract][Full Text] [Related]
32. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes. Zhang R; Qian J; Li X; Yuan Y Br J Ophthalmol; 2017 Dec; 101(12):1731-1738. PubMed ID: 28986343 [TBL] [Abstract][Full Text] [Related]
33. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells. Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475 [TBL] [Abstract][Full Text] [Related]
34. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963 [TBL] [Abstract][Full Text] [Related]
35. Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Shen J; Sun M; Ping Q; Ying Z; Liu W Nanotechnology; 2010 Jan; 21(2):025101. PubMed ID: 19955616 [TBL] [Abstract][Full Text] [Related]
36. Drug distribution in the vitreous humor of the human eye: the effects of aphakia and changes in retinal permeability and vitreous diffusivity. Friedrich S; Saville B; Cheng YL J Ocul Pharmacol Ther; 1997 Oct; 13(5):445-59. PubMed ID: 9326726 [TBL] [Abstract][Full Text] [Related]
37. Effect of particle size of polymeric nanospheres on intravitreal kinetics. Sakurai E; Ozeki H; Kunou N; Ogura Y Ophthalmic Res; 2001; 33(1):31-6. PubMed ID: 11114602 [TBL] [Abstract][Full Text] [Related]
39. The obstacle course to the inner retina: Hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane. Devoldere J; Wels M; Peynshaert K; Dewitte H; De Smedt SC; Remaut K Eur J Pharm Biopharm; 2019 Aug; 141():161-171. PubMed ID: 31150809 [TBL] [Abstract][Full Text] [Related]